SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-22-007645
Filing Date
2022-02-14
Accepted
2022-02-14 17:15:49
Documents
6
Period of Report
2022-03-11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea155687-def14a_silopharma.htm DEF 14A 150079
2 GRAPHIC image_001.jpg GRAPHIC 9111
3 GRAPHIC image_002.jpg GRAPHIC 2196
4 GRAPHIC image_003.jpg GRAPHIC 1727
5 GRAPHIC image_004.jpg GRAPHIC 1560
6 GRAPHIC image_005.jpg GRAPHIC 2767
  Complete submission text file 0001213900-22-007645.txt   176025
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-54872 | Film No.: 22634786
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl